EFPIA Newsletter 01 August 2024

European pharmaceutical industry calls for Competitiveness Strategy Nearly three-quarters of European science graduates choose to remain in the US in hubs like Boston and San Francisco after completing their doctorates. To build an eco-system for Europe to be the location for developing and manufacturing new technologies, we need to address EU skills gaps by improving STEM education. Read more in our Competitiveness Strategy for European Life Sciences.

Blogs     30 July 2024 Implementing Cancer Screening Programmes in the EU: key learnings in 4 Member States Late diagnosis of cancer has a significant impact on survival, quality of life, and treatment costs. Detecting it early... Read more →

The Pharmaceutical Industry in Figures 2024

The research-based biopharmaceutical industry is estimated to have invested €50,000 million in R&D in Europe in 2023. It is also the sector with the highest ratio of R&D investment to net sales. According to the 2023 EU Industrial R&D Investment Scoreboard, health industries invested about €261.4 billion in R&D in 2022, accounting for 20.9% of total business R&D expenditure worldwide. Read the full report here.

Events     12 AUG 2024   Explore innovative personalized therapeutic approaches for rare diseases Online course Learn how recent advances in medicine research are transforming the treatment of rare diseases. Learn more →       04 SEP 2024   Masterclass – how to unlock the potential of data sharing in collaborative projects... Online Join us for an interactive session that will introduce you to practical tools and resources to help you share data with... Learn more →

	24 SEP 2024			DIA Medical Information & Communications Conference London, UK The 2024 DIA Medical Information and Communications Conference is designed for medical information professionals and... Learn more →

	27 SEP 2024			Why tackling chronic disease is a priority for Europe: Restating the case for investing... Hybrid event - Bad Hofgastein, Austria As Europe faces demographic, economic, and geopolitical challenges that make it difficult to increase health budgets,... Learn more →

What we are reading EU needs Alzheimer’s plan with concrete measures and deadlines, says EPP’s SANT coordinator... 26 July 2024  (Euractiv) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe